Metformin and Aging: A Review Available to Purchase

https://www.calicolabs.com/team-member/rochelle-shelley-buffenstein/

2.

3.

Soria-Valles

C

,

Osorio

FG

,

Gutiérrez-Fernández

A

,

De Los Angeles

A

,

Bueno

C

,

Menéndez

P

, et al..

NF-κB activation impairs somatic cell reprogramming in ageing

.

Nat Cell Biol

.

2015

Aug

;

17

(

8

):

1004

–

13

.

https://doi.org/10.1038/ncb3207

[PubMed]

1465-7392

https://doi.org/10.1101/gad.197954.112

4.

Osorio

FG

,

Bárcena

C

,

Soria-Valles

C

,

Ramsay

AJ

,

de Carlos

F

,

Cobo

J

, et al..

Nuclear lamina defects cause ATM-dependent NF-κB activation and link accelerated aging to a systemic inflammatory response

.

Genes Dev

.

2012

Oct

;

26

(

20

):

2311

–

24

.

[PubMed]

0890-9369

https://doi.org/10.1038/s41556-018-0259-0

5.

Soria-Valles

C

,

Osorio

FG

,

Gutiérrez-Fernández

A

,

De Los Angeles

A

,

Bueno

C

,

Menéndez

P

, et al..

Retraction Note: NF-κB activation impairs somatic cell reprogramming in ageing

.

Nat Cell Biol

.

2019

Mar

;

21

(

3

):

410

.

[PubMed]

1465-7392

https://doi.org/10.1038/nature08221

6.

Harrison

DE

,

Strong

R

,

Sharp

ZD

,

Nelson

JF

,

Astle

CM

,

Flurkey

K

, et al..

Rapamycin fed late in life extends lifespan in genetically heterogeneous mice

.

Nature

.

2009

Jul

;

460

(

7253

):

392

–

5

.

[PubMed]

0028-0836

https://doi.org/10.1038/460331a

7.

Kaeberlein

M

,

Kennedy

BK

.

Ageing: A midlife longevity drug

.

Nature

.

2009

Jul

;

460

(

7253

):

331

–

2

.

[PubMed]

0028-0836

https://doi.org/10.3390/ijms19082325

8.

Walters

HE

,

Cox

LS

.

mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases

.

Int J Mol Sci

.

2018

Aug

;

19

(

8

):

E2325

.

[PubMed]

1661-6596

https://doi.org/10.1126/scitranslmed.aar4289

9.

Kaeberlein

M

,

Galvan

V

.

Rapamycin and Alzheimer’s disease: time for a clinical trial

.

Sci Transl Med

.

2019

Jan

;

11

(

476

):

eaar4289

.

[PubMed]

1946-6234

https://doi.org/10.1038/nm.4010

10.

Chang

J

,

Wang

Y

,

Shao

L

,

Laberge

RM

,

Demaria

M

,

Campisi

J

, et al..

Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice

.

Nat Med

.

2016

Jan

;

22

(

1

):

78

–

83

.

[PubMed]

1078-8956

https://doi.org/10.1038/nature13193

11.

van Deursen

JM

.

The role of senescent cells in ageing

.

Nature

.

2014

May

;

509

(

7501

):

439

–

46

.

[PubMed]

0028-0836

https://doi.org/10.1038/nrd.2017.116

12.

Childs

BG

,

Gluscevic

M

,

Baker

DJ

,

Laberge

RM

,

Marquess

D

,

Dananberg

J

, et al..

Senescent cells: an emerging target for diseases of ageing

.

Nat Rev Drug Discov

.

2017

Oct

;

16

(

10

):

718

–

35

.

[PubMed]

1474-1776

https://doi.org/10.1111/jgs.14969

13.

Kirkland

JL

,

Tchkonia

T

,

Zhu

Y

,

Niedernhofer

LJ

,

Robbins

PD

.

The Clinical Potential of Senolytic Drugs

.

J Am Geriatr Soc

.

2017

Oct

;

65

(

10

):

2297

–

301

.

[PubMed]

0002-8614

https://doi.org/10.1038/s41591-018-0092-9

14.

Xu

M

,

Pirtskhalava

T

,

Farr

JN

,

Weigand

BM

,

Palmer

AK

,

Weivoda

MM

, et al..

Senolytics improve physical function and increase lifespan in old age

.

Nat Med

.

2018

Aug

;

24

(

8

):

1246

–

56

.

[PubMed]

1078-8956

https://doi.org/10.4155/fmc-2018-0234

15.

Myrianthopoulos

V

.

The emerging field of senotherapeutic drugs

.

Future Med Chem

.

2018

Oct

;

10

(

20

):

2369

–

72

.

[PubMed]

1756-8919

https://doi.org/10.1111/acel.12344

16.

Zhu

Y

,

Tchkonia

T

,

Pirtskhalava

T

,

Gower

AC

,

Ding

H

,

Giorgadze

N

, et al..

The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs

.

Aging Cell

.

2015

Aug

;

14

(

4

):

644

–

58

.

[PubMed]

1474-9718

https://doi.org/10.1038/s41467-017-00314-z

17.

Fuhrmann-Stroissnigg

H

,

Ling

YY

,

Zhao

J

,

McGowan

SJ

,

Zhu

Y

,

Brooks

RW

, et al..

Identification of HSP90 inhibitors as a novel class of senolytics

.

Nat Commun

.

2017

Sep

;

8

(

1

):

422

.

[PubMed]

2041-1723

https://doi.org/10.1016/j.arr.2017.10.004

18.

Yanai

H

,

Fraifeld

VE

.

The role of cellular senescence in aging through the prism of Koch-like criteria

.

Ageing Res Rev

.

2018

Jan

;

41

:

18

–

33

.

[PubMed]

1568-1637

https://doi.org/10.1016/j.ebiom.2018.12.052

19.

Justice

JN

,

Nambiar

AM

,

Tchkonia

T

,

LeBrasseur

NK

,

Pascual

R

,

Hashmi

SK

, et al..

Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study

.

EBioMedicine

.

2019

Feb

;

40

:

554

–

63

.

[PubMed]

2352-3964

https://doi.org/10.1016/j.ebiom.2018.09.015

20.

Yousefzadeh

MJ

,

Zhu

Y

,

McGowan

SJ

,

Angelini

L

,

Fuhrmann-Stroissnigg

H

,

Xu

M

, et al..

Fisetin is a senotherapeutic that extends health and lifespan

.

EBioMedicine

.

2018

Oct

;

36

:

18

–

28

.

[PubMed]

2352-3964

https://doi.org/10.1016/j.tips.2018.09.008

21.

Schubert

D

,

Currais

A

,

Goldberg

J

,

Finley

K

,

Petrascheck

M

,

Maher

P

.

Geroneuroprotectors: Effective Geroprotectors for the Brain

.

Trends Pharmacol Sci

.

2018

Dec

;

39

(

12

):

1004

–

7

.

[PubMed]

0165-6147

https://doi.org/10.1016/j.neuint.2015.08.003

22.

Krasieva

TB

,

Ehren

J

,

O’Sullivan

T

,

Tromberg

BJ

,

Maher

P

.

Cell and brain tissue imaging of the flavonoid fisetin using label-free two-photon microscopy

.

Neurochem Int

.

2015

Oct

;

89

:

243

–

8

.

[PubMed]

0197-0186

https://doi.org/10.1021/acs.jafc.7b04265

23.

Zhang

X

,

Yin

J

,

Liang

C

,

Sun

Y

,

Zhang

L

.

UHPLC-Q-TOF-MS/MS Method Based on Four-Step Strategy for Metabolism Study of Fisetin in Vitro and in Vivo

.

J Agric Food Chem

.

2017

Dec

;

65

(

50

):

10959

–

72

.

[PubMed]

0021-8561

https://www.fightaging.org

24.

25.

Kaeberlein

M

.

How healthy is the healthspan concept

.

Geroscience

.

2018

Aug

;

40

(

4

):

361

–

4

.

https://doi.org/10.1007/s11357-018-0036-9

[PubMed]

2509-2715

https://doi.org/10.2165/11534750-000000000-00000

26.

Graham

GG

,

Punt

J

,

Arora

M

,

Day

RO

,

Doogue

MP

,

Duong

JK

, et al..

Clinical pharmacokinetics of metformin

.

Clin Pharmacokinet

.

2011

Feb

;

50

(

2

):

81

–

98

.

[PubMed]

0312-5963

https://doi.org/10.1007/s00125-008-1053-5

27.

Bailey

CJ

,

Wilcock

C

,

Scarpello

JH

.

Metformin and the intestine

.

Diabetologia

.

2008

Aug

;

51

(

8

):

1552

–

3

.

[PubMed]

0012-186X

https://doi.org/10.1053/j.gastro.2017.12.040

28.

Paleari

L

,

Burhenne

J

,

Weiss

J

,

Foersch

S

,

Roth

W

,

Parodi

A

, et al..

High Accumulation of Metformin in Colonic Tissue of Subjects With Diabetes or the Metabolic Syndrome

.

Gastroenterology

.

2018

Apr

;

154

(

5

):

1543

–

5

.

[PubMed]

0016-5085

https://doi.org/10.1080/17474124.2017.1273769

29.

Wu

T

,

Horowitz

M

,

Rayner

CK

.

New insights into the anti-diabetic actions of metformin: from the liver to the gut

.

Expert Rev Gastroenterol Hepatol

.

2017

Feb

;

11

(

2

):

157

–

66

.

[PubMed]

1747-4124

30.

Buse

JB

,

DeFronzo

RA

,

Rosenstock

J

,

Kim

T

,

Burns

C

,

Skare

S

, et al..

The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies

.

Diabetes Care

.

2016

Feb

;

39

(

2

):

198

–

205

.

[PubMed]

1935-5548

https://doi.org/10.1172/jci.insight.93936

31.

Bahne

E

,

Sun

EW

,

Young

RL

,

Hansen

M

,

Sonne

DP

,

Hansen

JS

, et al..

Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes

.

JCI Insight

.

2018

Dec

;

3

(

23

):

93936

.

[PubMed]

2379-3708

https://doi.org/10.15252/embr.201642195

32.

Pakos-Zebrucka

K

,

Koryga

I

,

Mnich

K

,

Ljujic

M

,

Samali

A

,

Gorman

AM

.

The integrated stress response

.

EMBO Rep

.

2016

Oct

;

17

(

10

):

1374

–

95

.

[PubMed]

1469-221X

https://doi.org/10.1101/677831

33.

Coll

AP

,

Chen

M

,

Taskar

P

,

Rimington

D

,

Patel

S

,

Tadross

J

, et al..

GDF15 and the beneficial actions of metformin in pre-diabetes

.

bioRxiv

.

34.

Musi

N

,

Hirshman

MF

,

Nygren

J

,

Svanfeldt

M

,

Bavenholm

P

,

Rooyackers

O

, et al..

Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes

.

Diabetes

.

2002

Jul

;

51

(

7

):

2074

–

81

.

https://doi.org/10.2337/diabetes.51.7.2074

[PubMed]

0012-1797

https://doi.org/10.1007/s00125-011-2126-4

35.

Boyle

JG

,

Logan

PJ

,

Jones

GC

,

Small

M

,

Sattar

N

,

Connell

JM

, et al..

AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study

.

Diabetologia

.

2011

Jul

;

54

(

7

):

1799

–

809

.

[PubMed]

0012-186X

https://doi.org/10.1210/jc.2018-02460

36.

Sun

EW

,

Martin

AM

,

Wattchow

DA

,

de Fontgalland

D

,

Rabbitt

P

,

Hollington

P

, et al..

Metformin Triggers PYY Secretion in Human Gut Mucosa

.

J Clin Endocrinol Metab

.

2019

Jul

;

104

(

7

):

2668

–

74

.

[PubMed]

0021-972X

https://doi.org/10.1098/rsob.190099

37.

Vara-Ciruelos

D

,

Russell

FM

,

Hardie

DG

.

The strange case of AMPK and cancer: Dr Jekyll or Mr Hyde? ^†

.

Open Biol

.

2019

Jul

;

9

(

7

):

190099

.

[PubMed]

2046-2441

https://doi.org/10.1016/j.cmet.2017.10.009

38.

Lin

SC

,

Hardie

DG

.

AMPK: Sensing Glucose as well as Cellular Energy Status

.

Cell Metab

.

2018

Feb

;

27

(

2

):

299

–

313

.

[PubMed]

1550-4131

https://doi.org/10.1186/s12915-016-0287-9

39.

Bridges

HR

,

Sirviö

VA

,

Agip

AN

,

Hirst

J

.

Molecular features of biguanides required for targeting of mitochondrial respiratory complex I and activation of AMP-kinase

.

BMC Biol

.

2016

Aug

;

14

(

1

):

65

.

[PubMed]

1741-7007

https://doi.org/10.3389/fphar.2019.00090

40.

Glossmann

HH

,

Lutz

OM

.

Commentary: Lactate-Induced Glucose Output Is Unchanged by Metformin at a Therapeutic Concentration-A Mass Spectrometry Imaging Study of the Perfused Rat Liver

.

Front Pharmacol

.

2019

Feb

;

10

:

90

.

[PubMed]

1663-9812

https://doi.org/10.1016/j.redox.2017.08.018

41.

Cameron

AR

,

Logie

L

,

Patel

K

,

Erhardt

S

,

Bacon

S

,

Middleton

P

, et al..

Metformin selectively targets redox control of complex I energy transduction

.

Redox Biol

.

2018

Apr

;

14

:

187

–

97

.

[PubMed]

2213-2317

https://doi.org/10.1074/jbc.RA118.003647

42.

Robb

EL

,

Hall

AR

,

Prime

TA

,

Eaton

S

,

Szibor

M

,

Viscomi

C

, et al..

Control of mitochondrial superoxide production by reverse electron transport at complex I

.

J Biol Chem

.

2018

Jun

;

293

(

25

):

9869

–

79

.

[PubMed]

0021-9258

https://doi.org/10.1016/j.cmet.2016.09.003

43.

Zhang

CS

,

Li

M

,

Ma

T

,

Zong

Y

,

Cui

J

,

Feng

JW

, et al..

Metformin Activates AMPK through the Lysosomal Pathway

.

Cell Metab

.

2016

Oct

;

24

(

4

):

521

–

2

.

[PubMed]

1550-4131

https://doi.org/10.1038/522265a

44.

Check Hayden

E

.

Anti-ageing pill pushed as bona fide drug

.

Nature

.

2015

Jun

;

522

(

7556

):

265

–

6

.

[PubMed]

0028-0836

https://doi.org/10.3389/fgene.2015.00205

45.

Bulterijs

S

,

Hull

RS

,

Björk

VC

,

Roy

AG

.

It is time to classify biological aging as a disease

.

Front Genet

.

2015

Jun

;

6

:

205

.

[PubMed]

1664-8021

https://doi.org/10.1016/S2213-8587(18)30234-1

46.

Armato

JP

,

DeFronzo

RA

,

Abdul-Ghani

M

,

Ruby

RJ

.

Successful treatment of prediabetes in clinical practice using physiological assessment (STOP DIABETES)

.

Lancet Diabetes Endocrinol

.

2018

Oct

;

6

(

10

):

781

–

9

.

[PubMed]

2213-8587

https://doi.org/10.1016/j.amjmed.2007.09.016

47.

Salpeter

SR

,

Buckley

NS

,

Kahn

JA

,

Salpeter

EE

.

Meta-analysis: metformin treatment in persons at risk for diabetes mellitus

.

Am J Med

.

2008

Feb

;

121

(

2

):

149

–

157.e2

.

[PubMed]

0002-9343

https://doi.org/10.4161/derm.23874

48.

Glossmann

H

,

Reider

N

.

A marriage of two “Methusalem” drugs for the treatment of psoriasis?: arguments for a pilot trial with metformin as add-on for methotrexate

.

Dermatoendocrinol

.

2013

Apr

;

5

(

2

):

252

–

63

.

[PubMed]

1938-1972

49.

Barzilai

NP

.

Session 1810 (Symposium)

.

Innov Aging

.

2018

;

2

:

544

–

5

.2399-5300

https://doi.org/10.1111/bph.13798

50.

Cha

Y

,

Erez

T

,

Reynolds

IJ

,

Kumar

D

,

Ross

J

,

Koytiger

G

, et al..

Drug repurposing from the perspective of pharmaceutical companies

.

Br J Pharmacol

.

2018

Jan

;

175

(

2

):

168

–

80

.

[PubMed]

0007-1188

51.

Espeland

MA

,

Crimmins

EM

,

Grossardt

BR

,

Crandall

JP

,

Gelfond

JA

,

Harris

TB

, et al.;

Multimorbidity Clinical Trials Consortium

.

Clinical Trials Targeting Aging and Age-Related Multimorbidity

.

J Gerontol A Biol Sci Med Sci

.

2017

Mar

;

72

(

3

):

355

–

61

.

[PubMed]

1758-535X

https://doi.org/10.1001/jama.2018.9562

52.

Barzilai

N

,

Cuervo

AM

,

Austad

S

.

Aging as a Biological Target for Prevention and Therapy

.

JAMA

.

2018

Oct

;

320

(

13

):

1321

–

2

.

[PubMed]

0098-7484

https://doi.org/10.1038/nrd.2018.134

53.

Mullard

A

.

Anti-ageing pipeline starts to mature

.

Nat Rev Drug Discov

.

2018

Sep

;

17

(

9

):

609

–

12

.

[PubMed]

1474-1776

https://doi.org/10.1093/gerona/glz078

54.

Espinoza

SE

,

Musi

N

,

Wang

CP

,

Michalek

J

,

Orsak

B

,

Romo

T

, et al..

Rationale and Study Design of a Randomized Clinical Trial of Metformin to Prevent Frailty in Older Adults with Pre-Diabetes

.

J Gerontol A Biol Sci Med Sci

.

2019

Mar

;

glz078

.

[PubMed]

1758-535X

https://doi.org/10.1007/s11357-019-00057-3

55.

Konopka

AR

,

Miller

BF

.

Taming expectations of metformin as a treatment to extend healthspan

.

Geroscience

.

2019

Apr

;

41

(

2

):

101

–

8

.

[PubMed]

2509-2715

https://doi.org/10.3310/hta22180

56.

Griffin

SJ

,

Bethel

MA

,

Holman

RR

,

Khunti

K

,

Wareham

N

,

Brierley

G

, et al..

Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT

.

Health Technol Assess

.

2018

Apr

;

22

(

18

):

1

–

64

.

[PubMed]

1366-5278

https://doi.org/10.1007/s11357-018-0042-y

57.

Justice

JN

,

Ferrucci

L

,

Newman

AB

,

Aroda

VR

,

Bahnson

JL

,

Divers

J

, et al..

A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup

.

Geroscience

.

2018

Dec

;

40

(

5-6

):

419

–

36

.

[PubMed]

2509-2715

https://doi.org/10.1111/acel.12723

58.

Kulkarni

AS

,

Brutsaert

EF

,

Anghel

V

,

Zhang

K

,

Bloomgarden

N

,

Pollak

M

, et al..

Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults

.

Aging Cell

.

2018

Apr

;

17

(

2

):

e12723

.

[PubMed]

1474-9718

https://doi.org/10.1038/s41556-018-0235-8

59.

Leidal

AM

,

Levine

B

,

Debnath

J

.

Autophagy and the cell biology of age-related disease

.

Nat Cell Biol

.

2018

Dec

;

20

(

12

):

1338

–

48

.

[PubMed]

1465-7392

https://doi.org/10.1016/j.tips.2018.10.005

60.

Ren

J

,

Zhang

Y

.

Targeting Autophagy in Aging and Aging-Related Cardiovascular Diseases

.

Trends Pharmacol Sci

.

2018

Dec

;

39

(

12

):

1064

–

76

.

[PubMed]

0165-6147

https://doi.org/10.1161/CIRCHEARTFAILURE.118.005418

61.

Kanamori

H

,

Naruse

G

,

Yoshida

A

,

Minatoguchi

S

,

Watanabe

T

,

Kawaguchi

T

, et al..

Metformin Enhances Autophagy and Provides Cardioprotection in δ-Sarcoglycan Deficiency-Induced Dilated Cardiomyopathy

.

Circ Heart Fail

.

2019

Apr

;

12

(

4

):

e005418

.

[PubMed]

1941-3289

https://doi.org/10.1089/ars.2017.7409

62.

Diaz-Morales

N

,

Iannantuoni

F

,

Escribano-Lopez

I

,

Bañuls

C

,

Rovira-Llopis

S

,

Sola

E

, et al..

Does Metformin Modulate Endoplasmic Reticulum Stress and Autophagy in Type 2 Diabetic Peripheral Blood Mononuclear Cells

.

Antioxid Redox Signal

.

2018

Jun

;

28

(

17

):

1562

–

9

.

[PubMed]

1523-0864

http://www.unz.com/jthompson/correlation-is-not-causation-but-its-the-way-to-bet/

63.

64.

Yerevanian

A

,

Soukas

AA

.

Metformin: Mechanisms in Human Obesity and Weight Loss

.

Curr Obes Rep

.

2019

Jun

;

8

(

2

):

156

–

64

.

https://doi.org/10.1007/s13679-019-00335-3

[PubMed]

2162-4968

https://doi.org/10.1111/liv.13872

65.

Tseng

CH

.

Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes

.

Liver Int

.

2018

Nov

;

38

(

11

):

2018

–

27

.

[PubMed]

1478-3223

https://doi.org/10.1007/s00125-012-2653-7

66.

Stevens

RJ

,

Ali

R

,

Bankhead

CR

,

Bethel

MA

,

Cairns

BJ

,

Camisasca

RP

, et al..

Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials

.

Diabetologia

.

2012

Oct

;

55

(

10

):

2593

–

603

.

[PubMed]

0012-186X

https://doi.org/10.1371/journal.pone.0033411

67.

Noto

H

,

Goto

A

,

Tsujimoto

T

,

Noda

M

.

Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis

.

PLoS One

.

2012

;

7

(

3

):

e33411

.

[PubMed]

1932-6203

https://doi.org/10.1371/journal.pmed.1001204

68.

Boussageon

R

,

Supper

I

,

Bejan-Angoulvant

T

,

Kellou

N

,

Cucherat

M

,

Boissel

JP

, et al..

Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials

.

PLoS Med

.

2012

;

9

(

4

):

e1001204

.

[PubMed]

1549-1277

https://doi.org/10.1007/s00125-017-4337-9

69.

Griffin

SJ

,

Leaver

JK

,

Irving

GJ

.

Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes

.

Diabetologia

.

2017

Sep

;

60

(

9

):

1620

–

9

.

[PubMed]

0012-186X

https://doi.org/10.1016/j.jdiacomp.2017.01.013

70.

Wang

CP

,

Lorenzo

C

,

Habib

SL

,

Jo

B

,

Espinoza

SE

.

Differential effects of metformin on age related comorbidities in older men with type 2 diabetes

.

J Diabetes Complications

.

2017

Apr

;

31

(

4

):

679

–

86

.

[PubMed]

1056-8727

https://doi.org/10.1016/j.arr.2017.08.003

71.

Campbell

JM

,

Bellman

SM

,

Stephenson

MD

,

Lisy

K

.

Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis

.

Ageing Res Rev

.

2017

Nov

;

40

:

31

–

44

.

[PubMed]

1568-1637

https://doi.org/10.1111/dom.12354

72.

Bannister

CA

,

Holden

SE

,

Jenkins-Jones

S

,

Morgan

CL

,

Halcox

JP

,

Schernthaner

G

, et al..

Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls

.

Diabetes Obes Metab

.

2014

Nov

;

16

(

11

):

1165

–

73

.

[PubMed]

1462-8902

73.

Xu

H

,

Aldrich

MC

,

Chen

Q

,

Liu

H

,

Peterson

NB

,

Dai

Q

, et al..

Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality

.

J Am Med Inform Assoc

.

2015

Jan

;

22

(

1

):

179

–

91

.

[PubMed]

1527-974X

https://doi.org/10.2337/dc18-1970

74.

Nathan

DM

,

Knowler

WC

,

Edelstein

S

,

Crandall

JP

,

Dabelea

D

,

Goldberg

RB

, et al.;

Diabetes Prevention Program Research Group

.

Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study

.

Diabetes Care

.

2019

Apr

;

42

(

4

):

601

–

8

.

[PubMed]

0149-5992

https://www.directclinicaltrial.org.uk/Pubfiles/Final%20accepted%20draft,%20prior%20to%20editing%20and%20corrections.pdf

75.

76.

Bonaccio

M

,

Di Castelnuovo

A

,

Costanzo

S

,

Gialluisi

A

,

Persichillo

M

,

Cerletti

C

, et al..

Mediterranean diet and mortality in the elderly: a prospective cohort study and a meta-analysis

.

Br J Nutr

.

2018

Oct

;

120

(

8

):

841

–

54

.

https://doi.org/10.1017/S0007114518002179

[PubMed]

0007-1145

https://doi.org/10.1056/NEJMoa1200303

77.

Estruch

R

,

Ros

E

,

Salas-Salvadó

J

,

Covas

MI

,

Corella

D

,

Arós

F

, et al.;

PREDIMED Study Investigators

.

Primary prevention of cardiovascular disease with a Mediterranean diet

.

N Engl J Med

.

2013

Apr

;

368

(

14

):

1279

–

90

.

[PubMed]

0028-4793

https://doi.org/10.1136/bmj.l341

78.

Agarwal

A

,

Ioannidis

JP

.

PREDIMED trial of Mediterranean diet: retracted, republished, still trusted

.

BMJ

.

2019

Feb

;

364

:

l341

.

[PubMed]

0959-8138

https://doi.org/10.1016/j.cmet.2016.05.011

79.

Barzilai

N

,

Crandall

JP

,

Kritchevsky

SB

,

Espeland

MA

.

Metformin as a Tool to Target Aging

.

Cell Metab

.

2016

Jun

;

23

(

6

):

1060

–

5

.

[PubMed]

1550-4131

https://doi.org/10.1016/j.ddmod.2018.11.001

80.

Mack

HID

,

Heimbucher

T

,

Murphy

CT

:

The nematode Caenorhabditis elegans as a model for aging research.

Drug Discov Today Dis Model. DOI:

81.

Onken

B

,

Driscoll

M

.

Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1

.

PLoS One

.

2010

Jan

;

5

(

1

):

e8758

.

https://doi.org/10.1371/journal.pone.0008758

[PubMed]

1932-6203

https://doi.org/10.1016/j.cmet.2019.01.018

82.

Madeo

F

,

Carmona-Gutierrez

D

,

Hofer

SJ

,

Kroemer

G

.

Caloric Restriction Mimetics against Age-Associated Disease: Targets, Mechanisms, and Therapeutic Potential

.

Cell Metab

.

2019

Mar

;

29

(

3

):

592

–

610

.

[PubMed]

1550-4131

https://doi.org/10.1073/pnas.1412192112

83.

Bansal

A

,

Zhu

LJ

,

Yen

K

,

Tissenbaum

HA

.

Uncoupling lifespan and healthspan in Caenorhabditis elegans longevity mutants

.

Proc Natl Acad Sci USA

.

2015

Jan

;

112

(

3

):

E277

–

86

.

[PubMed]

0027-8424

https://doi.org/10.1038/s41467-018-02934-5

84.

De Magalhaes Filho

CD

,

Henriquez

B

,

Seah

NE

,

Evans

RM

,

Lapierre

LR

,

Dillin

A

.

Visible light reduces C. elegans longevity

.

Nat Commun

.

2018

Mar

;

9

(

1

):

927

.

[PubMed]

2041-1723

https://doi.org/10.1016/j.cell.2013.02.035

85.

Cabreiro

F

,

Au

C

,

Leung

KY

,

Vergara-Irigaray

N

,

Cochemé

HM

,

Noori

T

, et al..

Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism

.

Cell

.

2013

Mar

;

153

(

1

):

228

–

39

.

[PubMed]

0092-8674

https://doi.org/10.1073/pnas.1321776111

86.

De Haes

W

,

Frooninckx

L

,

Van Assche

R

,

Smolders

A

,

Depuydt

G

,

Billen

J

, et al..

Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2

.

Proc Natl Acad Sci USA

.

2014

Jun

;

111

(

24

):

E2501

–

9

.

[PubMed]

0027-8424

https://doi.org/10.14348/molcells.2016.2368

87.

Rhee

SG

.

Overview on Peroxiredoxin

.

Mol Cells

.

2016

Jan

;

39

(

1

):

1

–

5

.

[PubMed]

1016-8478

https://doi.org/10.1074/jbc.C116.744037

88.

Kim

J

,

Lee

HY

,

Ahn

J

,

Hyun

M

,

Lee

I

,

Min

KJ

, et al..

NHX-5, an Endosomal Na+/H+ Exchanger, Is Associated with Metformin Action

.

J Biol Chem

.

2016

Aug

;

291

(

35

):

18591

–

9

.

[PubMed]

0021-9258

https://doi.org/10.7554/eLife.31268

89.

Chen

J

,

Ou

Y

,

Li

Y

,

Hu

S

,

Shao

LW

,

Liu

Y

.

Metformin extends C. elegans lifespan through lysosomal pathway

.

eLife

.

2017

Oct

;

6

:

e31268

.

[PubMed]

2050-084X

https://doi.org/10.1016/j.bbadis.2017.09.016

90.

Piper

MD

,

Partridge

L

.

Drosophila as a model for ageing

.

Biochim Biophys Acta Mol Basis Dis

.

2018

Sep

;

1864

(

9

9 Pt A

):

2707

–

17

.

[PubMed]

0925-4439

https://doi.org/10.1371/journal.pone.0047699

91.

Slack

C

,

Foley

A

,

Partridge

L

.

Activation of AMPK by the putative dietary restriction mimetic metformin is insufficient to extend lifespan in Drosophila

.

PLoS One

.

2012

;

7

(

10

):

e47699

.

[PubMed]

1932-6203

https://doi.org/10.1074/jbc.RA118.002025

92.

Prasad

H

,

Rao

R

.

Histone deacetylase-mediated regulation of endolysosomal pH

.

J Biol Chem

.

2018

May

;

293

(

18

):

6721

–

35

.

[PubMed]

0021-9258

https://doi.org/10.1002/iub.1633

93.

Kim

J

,

You

YJ

.

Regulation of organelle function by metformin

.

IUBMB Life

.

2017

Jul

;

69

(

7

):

459

–

69

.

[PubMed]

1521-6543

https://doi.org/10.1038/ncomms3192

94.

Martin-Montalvo

A

,

Mercken

EM

,

Mitchell

SJ

,

Palacios

HH

,

Mote

PL

,

Scheibye-Knudsen

M

, et al..

Metformin improves healthspan and lifespan in mice

.

Nat Commun

.

2013

;

4

(

1

):

2192

.

[PubMed]

2041-1723

https://doi.org/10.1111/acel.12496

95.

Strong

R

,

Miller

RA

,

Antebi

A

,

Astle

CM

,

Bogue

M

,

Denzel

MS

, et al..

Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer

.

Aging Cell

.

2016

Oct

;

15

(

5

):

872

–

84

.

[PubMed]

1474-9718

https://doi.org/10.1038/71641

96.

Beck

JA

,

Lloyd

S

,

Hafezparast

M

,

Lennon-Pierce

M

,

Eppig

JT

,

Festing

MF

, et al..

Genealogies of mouse inbred strains

.

Nat Genet

.

2000

Jan

;

24

(

1

):

23

–

5

.

[PubMed]

1061-4036

https://doi.org/10.5534/wjmh.180018

97.

Bartke

A

.

Growth Hormone and Aging: updated Review

.

World J Mens Health

.

2019

Jan

;

37

(

1

):

19

–

30

.

[PubMed]

2287-4208

https://doi.org/10.1210/jc.2018-01791

98.

Porter

KM

,

Ward

M

,

Hughes

CF

,

O’Kane

M

,

Hoey

L

,

McCann

A

, et al..

Hyperglycemia and metformin use are associated with B-vitamin deficiency and cognitive dysfunction in older adults

.

J Clin Endocrinol Metab

.

2019

Mar

;

jc.2018-01791

.

[PubMed]

0021-972X

https://doi.org/10.1139/H07-144

99.

Braun

B

,

Eze

P

,

Stephens

BR

,

Hagobian

TA

,

Sharoff

CG

,

Chipkin

SR

, et al..

Impact of metformin on peak aerobic capacity

.

Appl Physiol Nutr Metab

.

2008

Feb

;

33

(

1

):

61

–

7

.

[PubMed]

1715-5312

https://doi.org/10.1186/s13063-017-1932-5

100.

Long

DE

,

Peck

BD

,

Martz

JL

,

Tuggle

SC

,

Bush

HM

,

McGwin

G

, et al..

Metformin to Augment Strength Training Effective Response in Seniors (MASTERS): study protocol for a randomized controlled trial

.

Trials

.

2017

Apr

;

18

(

1

):

192

.

[PubMed]

1745-6215

https://doi.org/10.7554/eLife.31157

101.

Ruby

JG

,

Smith

M

,

Buffenstein

R

.

Naked Mole-Rat mortality rates defy gompertzian laws by not increasing with age

.

eLife

.

2018

Jan

;

7

:

e31157

.

[PubMed]

2050-084X